Related Experiment Video
Updated: Jul 18, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation
Chun Zhao1, Yi Yin1, Tianxin Zhang2
1Department of Pediatric intensive care unit, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, P.R. China.
Insights
Dexmedetomidine sedation in children with severe sepsis and mechanical ventilation reduced 28-day mortality. This sedative may improve outcomes in pediatric severe sepsis patients.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Sepsis Research
Background:
- Severe sepsis poses a significant mortality risk in children.
- Dexmedetomidine, a sedative, has demonstrated mortality benefits in adult severe sepsis.
- The efficacy of dexmedetomidine in pediatric severe sepsis remains under investigation.
Purpose of the Study:
- To investigate the impact of dexmedetomidine on mortality and clinical outcomes in mechanically ventilated children with severe sepsis.
- To compare outcomes between children receiving dexmedetomidine and those not receiving it for sedation.
Main Methods:
- Retrospective cohort study of children with severe sepsis requiring mechanical ventilation (2016-2020).
- Propensity score matching used to create comparable dexmedetomidine and non-dexmedetomidine groups (61 children each).
- Primary outcome: 28-day mortality. Secondary outcomes: acute kidney injury, ventilator-free days, PICU/hospital length of stay.
Main Results:
- Dexmedetomidine group had significantly lower 28-day mortality (9.84% vs. 26.23%, P=0.008).
- The dexmedetomidine group showed lower day 7 neurological and renal sub-scores and improved day 3/7 serum creatinine levels.
- No significant differences observed in acute kidney injury incidence, ventilator-free days, or lengths of PICU/hospital stays.
Conclusions:
- Dexmedetomidine treatment is associated with improved outcomes in pediatric severe sepsis.
- Consideration of dexmedetomidine as a sedation strategy in this patient population is warranted.
- Further research may explore specific benefits and optimal use in children.
Background:
The sedative dexmedetomidine has been shown to reduce mortality in adult patients with severe sepsis, but it is not known whether children benefit. This study explored the effects of dexmedetomidine on the outcomes of children with severe sepsis with mechanical ventilation.
Methods:
In this retrospective cohort study, children with severe sepsis requiring mechanical ventilation from 2016 to 2020 were categorized as dexmedetomidine and non-dexmedetomidine group. The propensity score matching was performed to match cases in both groups. The primary outcome was 28-day mortality, and the secondary outcomes were acute kidney injury, ventilator-free days, lengths of PICU and hospital stays. The Kaplan-Meier method and was the log-rank test used to estimate the 28-day mortality rate and assess between-group differences.
Results:
In total, 250 patients were eligible patients: 138 in the dexmedetomidine group and 112 in the non-dexmedetomidine group. After 1:1 propensity score matching, 61 children in each group. dexmedetomidine group showed more lower 28-day mortality (9.84% vs. 26.23%, P = 0.008). During the 7-day observation period after PICU admission, the dexmedetomidine group showed significantly lower neurological and renal sub-scores at day 7 and serum creatinine level at day 3 and day 7. There were no statistical differences in the incidence of acute kidney injury, ventilator-free days, lengths of PICU and hospital stays between the two groups.
Conclusions:
dexmedetomidine treatment in children with severe sepsis is associated with better outcomes and should therefore be considered for the sedation strategy.
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Cardiopulmonary Resuscitation IV: Pharmacological Management
Depolarizing Blockers: Pharmocokinetics
Mechanical Ventilation I: Indication and Settings
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...

